George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan Restructure and Equity Issue

31 Jul 2020 10:45

RNS Number : 7739U
Oilex Ltd
31 July 2020
 

ASX-RNS Announcement

 

 

31 July 2020

 

ASX: OEX

AIM: OEX

Loan Restructure and Equity Issue

 

The Board of Oilex Limited (the Company) is pleased to announce that it has taken further steps to strengthen its balance sheet as the Company continues to navigate the impact of Covid-19 on its business and global equity markets. In particular, the Company has entered into an amendment agreement to vary the repayment obligations for its Series C (GBP£125,000) loan. Furthermore, the Company has secured additional equity investment of £0.25 million to increase its working capital flexibility and reduce its financial debt obligations.

 

Amendment to Series C Loan Funding Agreement (GBP £125,000)

 

Pursuant to the amendment agreement, the loan repayment date has been extended from 1 August 2020 to 31 October 2020. All other terms remain the same and are extended to 31 October 2020, except for the issue of new options with an expiry date of 29 January 2021. A summary of key terms after the amendment are outlined below:

 

Term: 31 October 2020

Interest Rate: 5%

Repayments 100% payable at maturity

Options Issued: 113,636,364 options over ordinary shares

Option Exercise Price: £0.0011 per option

Option Expiry Date: On 29 January 2021

Security: Unsecured

Key Undertakings: Not to dispose of assets having an aggregate value more than A$1 million

Not to incur any financial indebtedness more than A$50,000

Not to incur any aggregate payment or outgoing exceeding A$1 million (except for wages)

 

Customary additional provisions regarding events of default, undertakings, covenants and representations and warranties remain unchanged.

 

The options, which if exercised in their entirety, will result in a cash inflow to the Company of £125,000 (A$224,901). The proceeds from such conversion of options will be applied to the outstanding Series C Loan balance, which is fully drawn down.

 

The issue of the new options is subject to shareholder approval under ASX Listing Rule 7.1 on or before 30 November 2020. Failure to secure shareholder approval will require immediate repayment of the loan principal and accrued interest.

 

Related Party Transaction under AIM

 

Republic Investment Management Pte Ltd (Republic) makes up all of the Series C Loan balance of £125,000. Republic has a shareholding in the Company of 11.88% and is therefore categorised as a Substantial Shareholder of the Company pursuant to the AIM Rules for Companies (AIM Rules). Accordingly, the entering into the amendment agreement with Republic is classified as a related party transaction pursuant to the AIM Rules.

 

 

 

The Directors of the Company, having consulted with Strand Hanson Limited, the Company's Nominated Adviser, consider that the terms of the amendment agreement with Republic are fair and reasonable insofar as the Company's shareholders are concerned.

 

Equity Capital Raising

 

The Company has arranged an equity capital raising, through Novum Securities Limited and to existing institutional shareholders, to secure further funding of £0.25 million (A$0.5 million) through the subscription of 312,500,000 new shares at GBP 0.08 pence (0.144 AUD cents) per share (Subscription).

 

Funds raised from the Subscription are intended to be applied towards increasing the Company's working capital base and debt reduction The additional funding will support the Company's initiative to implement the settlement with GSPC, which has been delayed by the impact from Covid-19. Completion of the Subscription is anticipated on or about 14 August 2020 and is conditional, inter alia, upon admission of the shares the subject of the Subscription to trading on AIM.

 

Pursuant to advisory agreements with Novum, the Company will issue 15,000,000 unlisted options exercisable at 0.08 pence on or before two years following the completion with the capital raising.

 

The shares, the subject of the Subscription, will rank pari passu in all respects with the existing shares. Application will be made in due course to the London Stock Exchange for the shares (Subscription Shares) to be admitted to trading on AIM with a further announcement at that time. The issue of the Subscription Shares is under Listing Rule 7.1 with the applicable Appendix 3B to be submitted shortly.

 

Following admission of the Subscription shares, the Company's share capital and total voting rights will comprise 4,119,629,999 shares. The Company does not hold any shares in treasury. Consequently, 4,119,629,999 is the figure which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Managing Director of Oilex, Joe Salomon, said;

 

"The Company continues to see advances in its flagship Cambay gas project in India, the sale of Bhandut together with the spin out of the Cooper Basin albeit the impact of COVID has increased response times in both India and Australia.

 

Reflecting the extended time frames, the Company has taken every step to reduce its costs including a very significant reduction in staff costs and overheads, both in Australia and India. These efforts ensure that the Company's funding requirements are minimised while it implements the settlement with GSPC, sale of Bhandut and the Armour transaction.

 

We remain confident of successful outcome and we thank our shareholders for their ongoing support and patience."

 

For and on behalf of Oilex Ltd

 

 

Joe Salomon

Managing Director

 

 

 

For further information, please contact:

 

Investor Enquires

Oilex Ltd

Joe Salomon

Managing Director

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel:+ 44 20 7390 0230 UK

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKKDBQCBKKNON
Date   Source Headline
24th Oct 20169:56 amRNSQuarterly Report 30 September 2016
24th Oct 20169:08 amRNSOilex Investor Presentation October 2016
24th Oct 20168:58 amRNS2016 Annual Report to Shareholders
24th Oct 20168:33 amRNS2016 AGM Notice of Meeting and Proxy Form
24th Oct 20168:29 amRNS2016 AGM Notice of Meeting
17th Oct 20167:00 amRNSAgreement with GSPC on Cambay-78 Well
29th Sep 20169:03 amRNSAppendix 4G
29th Sep 20169:03 amRNSFinancial Report for year ended 30 June 2016
29th Sep 20168:35 amRNSOilex Corporate Update
25th Aug 20167:00 amRNSExpiry of Unlisted Options
29th Jul 20167:00 amRNSQuarterly Report 30 June 2016
28th Jun 20167:00 amRNSExpiry of Unlisted Options
27th Jun 20167:00 amRNSOilex Investor Presentation June 2016
24th Jun 201610:48 amRNSOilex Corporate Update
10th Jun 201610:17 amRNSAppointment of CFO
8th Jun 20167:00 amRNSZeta Legal Proceedings Settlement
24th May 20168:09 amRNSExecutive Management Changes
18th May 20167:00 amRNSNotification of Major Interest in Shares
17th May 20167:21 amRNSNotification of Major Interest in Shares
6th May 20167:00 amRNSCancellation of Unlisted Options
29th Apr 20168:39 amRNSQuarterly Report 31 March 2016
8th Apr 20167:00 amRNSCommencement of Gas Production from Bhandut Field
18th Mar 20167:00 amRNSOilex Appoints New MD - Jonathan Salomon
18th Mar 20167:00 amRNSAppendix 3Z R Miller
14th Mar 20167:00 amRNSInterim Report 31 December 2015
8th Mar 20167:00 amRNSExpiry of Unlisted Options
1st Mar 20167:00 amRNSZeta Legal Proceedings Update
11th Feb 20167:00 amRNSOilex Strengthens Board with Appointment of NED
11th Feb 20167:00 amRNSAppendix 3X B Lingo
29th Jan 20167:00 amRNSQuarterly Report 31 December 2015
6th Jan 20167:00 amRNSExpiry of Unlisted Options
21st Dec 20157:00 amRNSIndia Operations Update
18th Dec 20157:00 amRNSZeta Legal Proceedings Update
8th Dec 20157:00 amRNSCambay Workover Update
2nd Dec 20159:40 amRNSZeta Legal Proceedings Update
1st Dec 20157:00 amRNSAppendix 3X J Salomon
30th Nov 20157:00 amRNSDirector Appointment
26th Nov 201510:37 amRNSASX Trading Halt
25th Nov 20157:40 amRNSAppendix 3Z J Auld
25th Nov 20157:35 amRNSAppendix 3Z S Bhandari
25th Nov 20157:32 amRNSResults of Annual General Meeting 25 November 2015
25th Nov 20157:00 amRNSCorporate Presentation November 2015
25th Nov 20157:00 amRNSChairman's Address to Shareholders
20th Nov 201512:58 pmRNSAppendix 3Y - S Bhandari
18th Nov 20153:00 pmRNSWithdrawal of Resolution
17th Nov 20151:50 pmRNSIndia Workover Update
13th Nov 20151:00 pmRNSEnd of Trading Halt on ASX
13th Nov 20158:23 amRNSUK Broker
12th Nov 20151:10 pmRNSZeta Update and Legal Proceedings
12th Nov 20157:00 amRNSTrading Halt

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.